SWC
HUMA icon

Spectrum Wealth Counsel’s Humacyte HUMA Stock Holding History

Spectrum Wealth Counsel’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$341 Hold
200
– – ﹤0.01% 353
2024
Q4 		$1.01K Hold
200
– – ﹤0.01% 337
2024
Q3 		$1.09K Hold
200
– – ﹤0.01% 360
2024
Q2 		$960 Buy
+200
New +$1.04K ﹤0.01% 357

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Spectrum Wealth Counsel's HUMA Position: Q1 2025 in Review

Spectrum Wealth Counsel held its Humacyte (HUMA) position steady in Q1 2025 at 200 shares worth $341. The position accounts for ﹤0.01% of the portfolio, ranked #353.

Spectrum Wealth Counsel first reported a position in HUMA in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.09K in Q3 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Spectrum Wealth Counsel held 200 shares of Humacyte worth $341 as of Q1 2025.
  • Spectrum Wealth Counsel left its Humacyte share count unchanged in Q1 2025.
  • Humacyte made up ﹤0.01% of Spectrum Wealth Counsel's portfolio in Q1 2025, its #353 holding.
  • Spectrum Wealth Counsel first reported a position in Humacyte in Q2 2024 and has held it in 4 quarters since.
  • Spectrum Wealth Counsel's Humacyte position peaked at $1.09K in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Spectrum Wealth Counsel's 13F filing for Q1 2025, filed 7 May 2025.